↓ Skip to main content

Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results

Overview of attention for article published in Stem Cell Research & Therapy, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results
Published in
Stem Cell Research & Therapy, January 2020
DOI 10.1186/s13287-020-1549-6
Pubmed ID
Authors

Emin ÖZMERT, Umut ARSLAN

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 14%
Student > Bachelor 8 14%
Other 4 7%
Student > Ph. D. Student 4 7%
Professor 2 4%
Other 9 16%
Unknown 21 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 21%
Medicine and Dentistry 9 16%
Nursing and Health Professions 4 7%
Engineering 3 5%
Immunology and Microbiology 1 2%
Other 2 4%
Unknown 25 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2023.
All research outputs
#2,399,277
of 25,032,929 outputs
Outputs from Stem Cell Research & Therapy
#167
of 2,716 outputs
Outputs of similar age
#56,029
of 469,858 outputs
Outputs of similar age from Stem Cell Research & Therapy
#4
of 82 outputs
Altmetric has tracked 25,032,929 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,716 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 469,858 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.